title: The contribution of apixaban renal clearance to total clearance.
authors.affiliation: Bristol-Myers Squibb, Princeton, NJ, USA. charles.frost@bms.com.
authors.forename: Charles
authors.initials: C
authors.lastname: Frost
authors.affiliation: Pfizer Inc, Groton, CT, USA. rebecca.boyd@pfizer.com.
authors.forename: Rebecca A
authors.initials: RA
authors.lastname: Boyd
mesh_terms: D005260:Female; D006801:Humans; D007668:Kidney / Q000378:metabolism*; D008297:Male; D011720:Pyrazoles / Q000008:administration & dosage / Q000493:pharmacokinetics*; D011728:Pyridones / Q000008:administration & dosage / Q000493:pharmacokinetics*
chemical_list: D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban